Search
Displaying 41–50 of 1172 results
-
Cincinnati/Northern Kentucky Chapter Social
- Aug 8, 2026
- 1:00 p.m. - 5:00 p.m. (EDT)
- 6061 Radio Way, Mason, OH 45040
Community EventJoin the Cincinnati/Northern Kentucky Chapter for an afternoon of connection and community.
-
Triangle-Triad Chapter Lunch and Learn (August)
- Aug 7, 2026
- 12:00 p.m. (EDT)
- Virtual
Community EventUnited in VISIONS - Reliving the highlights
-
Chicago Chapter Leadership Meeting (August)
- Aug 6, 2026
- 12:00 p.m. - 1:00 p.m. (CDT)
- Virtual
Community EventJoin us for our upcoming Chicago Chapter Meeting as we come together to connect, share updates, and continue driving progress toward treatments and cures for blinding diseases.
-
Triangle-Triad Chapter Axe Throwing: Aim High with Us!
- Jul 30, 2026
- 6:00 p.m. (EDT)
- 619 Foster St, Durham, NC 27701
Community EventTriangle-Triad Chapter Axe Throwing: Aim High with Us!
-
Sepul Bio completes clinical trial enrollment for its USH2A retinitis pigmentosa treatment
Research NewsUltevursen from Sepul Bio progresses through phase 2b safety and efficacy clinical trial
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Fiscal Year 2026 (July 1, 2025 – June 30, 2026)
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Fiscal Year 2025 (July 1, 2024 – June 30, 2025)
-
FDA approves Lumvoa, a new treatment for thyroid eye disease
Research NewsApproval gives patients an additional option to manage TED symptoms
-
Living Life Through My Eyes: My Journey with XLRS
Invisible DisabilityThere are moments when I wish I could see the world the way everyone else does. But I’ve realized that focusing on what I’ve lost only takes away from what I still have. XLRS may affect my eyesight, but it doesn’t define who I am.
-
Belite Bio Submits New Drug Application to FDA for its Stargardt Treatment
Research NewsTinlarebant becomes first Stargardt treatment submitted to FDA for approval
